121 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
trials, including the enrollment of
Vir’s clinical trials, and the expected timing of data readouts and presentations; the potential benefits, safety
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
, and the expected timing of data readouts and presentations; the potential benefits, safety, and efficacy of Vir’s investigational therapies; and risks … and actual results, including uncertainty as to whether the anticipated benefits of the BARDA collaboration can be achieved; unexpected safety or efficacy
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
safety events; risks of unexpected costs, delays or other unexpected hurdles; difficulties in collaborating with other companies; successful
S-3ASR
EX-1.2
VIR
Vir Biotechnology Inc
3 Nov 23
Automatic shelf registration
4:33pm
enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances
8-K
EX-99.1
5olrnlq4
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
zxd dgwxe40
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
4x7skqkn73t0 9t6ki
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
msdscav0 k7
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
msfpxwh t1rop41vcm2g
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
EX-99.1
is5vd7bf5vyd9qas1m
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
sc13e 0gkti0t3uw
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
ezei8wlwaaxgjm
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am
8-K
EX-99.1
d7lu9
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am